Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus

BACKGROUND: Metformin is a first-line drug in type 2 diabetes mellitus (T2DM) treatment, yet whether metformin may increase all-cause or cardiovascular mortality of T2DM patients remains inconclusive. METHODS: We searched PubMed and Embase for data extracted from inception to July 14, 2020, with a r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Main Authors: Li, Tian, Providencia, Rui, Mu, Nan, Yin, Yue, Chen, Mai, Wang, Yishi, Liu, Manling, Yu, Lu, Gu, Chunhu, Ma, Heng
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847575/
https://ncbi.nlm.nih.gov/pubmed/33516224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01202-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados